메뉴 건너뛰기




Volumn 147, Issue 3, 2004, Pages 440-441

N-acetylcysteine to prevent contrast nephropathy

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CONTRAST MEDIUM; PLACEBO;

EID: 2342421435     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.01.011     Document Type: Note
Times cited : (3)

References (18)
  • 1
    • 0020657043 scopus 로고
    • Hospital-acquired renal insufficiency: A prospective study
    • Hou S.H., Bushinsky D.A., Wish J.B., et al. Hospital-acquired renal insufficiency a prospective study. Am J Med. 74:1983;243-248
    • (1983) Am J Med , vol.74 , pp. 243-248
    • Hou, S.H.1    Bushinsky, D.A.2    Wish, J.B.3
  • 2
    • 0024504484 scopus 로고
    • Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization: A prospective trial
    • Davidson C.J., Hlatky M., Morris K.G., et al. Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization a prospective trial. Ann Intern Med. 110:1989;119-124
    • (1989) Ann Intern Med , vol.110 , pp. 119-124
    • Davidson, C.J.1    Hlatky, M.2    Morris, K.G.3
  • 3
    • 0028490756 scopus 로고
    • Contrast nephrotoxicity
    • Barrett B. Contrast nephrotoxicity. J Am Soc Nephrol. 5:1994;125-137
    • (1994) J Am Soc Nephrol , vol.5 , pp. 125-137
    • Barrett, B.1
  • 4
    • 0020514734 scopus 로고
    • Predicting angiography-induced acute renal function impairment: Clinical risk model
    • Cochran S.T., Wong W.S., Roe D.J. Predicting angiography-induced acute renal function impairment clinical risk model. Am J Roentgenol. 141:1983;1027-1033
    • (1983) Am J Roentgenol , vol.141 , pp. 1027-1033
    • Cochran, S.T.1    Wong, W.S.2    Roe, D.J.3
  • 5
    • 0026524974 scopus 로고
    • Radiocontrast-induced nephropathy in humans: Role of renal vasoconstriction
    • Weisberg L.S., Kurnik P.B., Kurnik B.R. Radiocontrast-induced nephropathy in humans role of renal vasoconstriction. Kidney International. 41:1992;1408-1415
    • (1992) Kidney International , vol.41 , pp. 1408-1415
    • Weisberg, L.S.1    Kurnik, P.B.2    Kurnik, B.R.3
  • 6
    • 0028035190 scopus 로고
    • Contrast-associated nephropathy: Presentation, pathophysiology and management
    • Porter G.A. Contrast-associated nephropathy presentation, pathophysiology and management. Mineral Electrolyte Metab. 20:1994;232-243
    • (1994) Mineral Electrolyte Metab , vol.20 , pp. 232-243
    • Porter, G.A.1
  • 7
    • 0025019379 scopus 로고
    • Radiocontrast medium-induced declines in renal function: A role for oxygen free radicals
    • Bakris G.L., Lass N., Gaber A.O., et al. Radiocontrast medium-induced declines in renal function a role for oxygen free radicals. Am J Physiol. 258:1990;F115-120
    • (1990) Am J Physiol , vol.258 , pp. 115-120
    • Bakris, G.L.1    Lass, N.2    Gaber, A.O.3
  • 8
    • 0028033015 scopus 로고
    • Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents
    • Solomon R., Werner C., Mann D., et al. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med. 331:1994;1416-1420
    • (1994) N Engl J Med , vol.331 , pp. 1416-1420
    • Solomon, R.1    Werner, C.2    Mann, D.3
  • 9
    • 0028197346 scopus 로고
    • Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application
    • Erley C.M., Duda S.H., Schlepckow S., et al. Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application. Kidney International. 45:1994;1425-1431
    • (1994) Kidney International , vol.45 , pp. 1425-1431
    • Erley, C.M.1    Duda, S.H.2    Schlepckow, S.3
  • 10
    • 0035511838 scopus 로고    scopus 로고
    • Aminophylline does not protect against radiocontrast nephropathy in patients undergoing percutaneous angiographic procedures
    • Shammas N.W., Kapalis M.J., Harris M., et al. Aminophylline does not protect against radiocontrast nephropathy in patients undergoing percutaneous angiographic procedures. J Invas Cardiol. 13:2001;738-740
    • (2001) J Invas Cardiol , vol.13 , pp. 738-740
    • Shammas, N.W.1    Kapalis, M.J.2    Harris, M.3
  • 11
    • 0030007676 scopus 로고    scopus 로고
    • Use of dopamine in prevention of contrast-induced acute renal failure: A randomised study
    • Kapoor A., Sinha N., Sharma R.K., et al. Use of dopamine in prevention of contrast-induced acute renal failure a randomised study. Int J Cardiol. 53:1996;233-236
    • (1996) Int J Cardiol , vol.53 , pp. 233-236
    • Kapoor, A.1    Sinha, N.2    Sharma, R.K.3
  • 12
    • 0031897391 scopus 로고    scopus 로고
    • Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy
    • Kurnik B.R., Allgren R.L., Genter F.C., et al. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kid Dis. 31:1998;674-680
    • (1998) Am J Kid Dis , vol.31 , pp. 674-680
    • Kurnik, B.R.1    Allgren, R.L.2    Genter, F.C.3
  • 13
    • 0024938617 scopus 로고
    • Prevention of radiocontrast-media-induced nephrotoxicity by the calcium channel blocker nitrendipine: A prospective randomised clinical trial
    • Neumayer H.H., Junge W., Kufner A., et al. Prevention of radiocontrast-media-induced nephrotoxicity by the calcium channel blocker nitrendipine a prospective randomised clinical trial. Nephrol Dials Transplant. 4:1989;1030-1036
    • (1989) Nephrol Dials Transplant , vol.4 , pp. 1030-1036
    • Neumayer, H.H.1    Junge, W.2    Kufner, A.3
  • 14
    • 0033631889 scopus 로고    scopus 로고
    • Prostaglandin E1: A new agent for the prevention of renal dysfunction in high risk patients caused by radiocontrast media?
    • Koch J.A., Plum J., Grabensee B., et al. Prostaglandin E1 a new agent for the prevention of renal dysfunction in high risk patients caused by radiocontrast media? Nephrol Dial Transplant. 15:2000;43-49
    • (2000) Nephrol Dial Transplant , vol.15 , pp. 43-49
    • Koch, J.A.1    Plum, J.2    Grabensee, B.3
  • 15
    • 0034115616 scopus 로고    scopus 로고
    • Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism
    • Wang A., Holcslaw T., Bashore T.M., et al. Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. Kidney International. 57:2000;1675-1680
    • (2000) Kidney International , vol.57 , pp. 1675-1680
    • Wang, A.1    Holcslaw, T.2    Bashore, T.M.3
  • 16
    • 0242493661 scopus 로고    scopus 로고
    • Fenoldopam mesylate for the prevention of contrast-induced nephropathy: A randomized controlled trial
    • Stone G.W., McCullough P.A., Tumlin J.A., et al. Fenoldopam mesylate for the prevention of contrast-induced nephropathy a randomized controlled trial. JAMA. 290:2003;2284-2291
    • (2003) JAMA , vol.290 , pp. 2284-2291
    • Stone, G.W.1    McCullough, P.A.2    Tumlin, J.A.3
  • 17
    • 0030764921 scopus 로고    scopus 로고
    • N-acetyl cysteine ameliorates ischemic renal failure
    • DiMari J., Megyesi J., Udvarhelyi N., et al. N-acetyl cysteine ameliorates ischemic renal failure. Am J Physiol. 272:1997;F292-298
    • (1997) Am J Physiol , vol.272 , pp. 292-298
    • Dimari, J.1    Megyesi, J.2    Udvarhelyi, N.3
  • 18
    • 3042648465 scopus 로고    scopus 로고
    • Montvale (NJ): Thomson PDR
    • Drug Topics Redbook. 2003;Thomson PDR, Montvale (NJ)
    • (2003) Drug Topics Redbook


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.